Statistics
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine
| Views | |
|---|---|
| Evaluating ... | 1475 |
Total Visits Per Month
| January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | |
|---|---|---|---|---|---|---|---|
| Evaluating ... | 18 | 21 | 27 | 41 | 30 | 21 | 12 |
File Visits
| Views | |
|---|---|
| 21VmhogDXFlrE.pdf | 855 |
